Canada· CA-DIN-02302578

WINRHO SDF

A anti-d (rh) immunoglobulin product containing anti-d (rh) immunoglobulin (human), registered in Canada by KI BIOPHARMA LLC. The same ATC class is registered in 11 of our 19 countries.

ATC J06BB01

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedWINRHO SDFATCJ06BB01REGISTER NO.CA-DIN-02302578PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Anti-d (rh) immunoglobulin is registered in 11 of 19 countries.

Countries holding a registration under ATC J06BB01 (anti-d (rh) immunoglobulin), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose

Anti-d (rh) immunoglobulin · ATC J06BB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
ANTI-D (RH) IMMUNOGLOBULIN (HUMAN)
Manufacturer
KI BIOPHARMA LLC
Country
Canada (CA)
ATC code
J06BB01
ATC class
Anti-D (rh) immunoglobulin
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Anti-d (rh) immunoglobulin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All anti-d (rh) immunoglobulin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Rhesonativ, Rhophylac
  • Belgium · Immunorho, Rhophylac
  • Bulgaria · Резонатив
  • Cyprus · Rhesonativ, Rhophylac
  • Czechia · Igamad, Rhesonativ
  • Germany · Rhesonativ, Rhophylac
  • Denmark · Rhesonativ, Rhophylac
  • Estonia · Rhesonativ
  • Spain · Igamad, Rhophylac
  • Finland · Rhophylac
  • France · Rhesonativ, Rhophylac
  • United Kingdom (Northern Ireland) · D-Gam, Rhophylac
  • Greece · Rhophylac
  • Hungary · Rhesonativ, Rhophylac
  • Ireland · Rhophylac
  • Iceland · Rhesonativ, Rhophylac
  • Italy · Igamad, Immunorho
  • Lithuania · Rhesonativ
  • Luxembourg · Rhesonativ, Rhophylac
  • Latvia · Rhesonativ
  • Malta · Rhesonativ, Rhophylac
  • Netherlands · Rhesonativ, Rhophylac
  • Norway · Rhesonativ, Rhophylac
  • Poland · Gamma Anty-D, Rhesonativ
  • Portugal · Rhesonativ, Rhophylac
  • Romania · Rhesonativ, Rhophylac
  • Sweden · Rhesonativ, Rhophylac
  • Slovenia · Rhesonativ, Rhophylac
  • Slovakia · Igamad, Rhesonativ

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad68c918-d250-45c0-a001-76ceb0c8c5d6
GET /v1/drugs/ad68c918-d250-45c0-a001-76ceb0c8c5d6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02302578",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAMUSCULAR",
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "J06BB01",
  "schedule": [
    "Schedule D"
  ],
  "drug_code": "78788",
  "strengths": [
    "1500 UNIT"
  ],
  "ahfs_class": null,
  "substances": [
    "ANTI-D (RH) IMMUNOGLOBULIN (HUMAN)"
  ],
  "product_categorization": null
}

See everything about anti-d (rh) immunoglobulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.